Intervacc AB (IVACC) - Total Liabilities

Latest as of September 2025: Skr18.76 Million SEK ≈ $2.02 Million USD

Based on the latest financial reports, Intervacc AB (IVACC) has total liabilities worth Skr18.76 Million SEK (≈ $2.02 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Intervacc AB - Total Liabilities Trend (2013–2024)

This chart illustrates how Intervacc AB's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Intervacc AB to evaluate short-term liquidity relative to the company's equity base.

Intervacc AB Competitors by Total Liabilities

The table below lists competitors of Intervacc AB ranked by their total liabilities.

Company Country Total Liabilities
B&B Triplewall Containers Limited
NSE:BBTCL
India Rs2.84 Billion
Victory Square Technologies Inc
F:6F6
Germany €8.17 Million
Moneyme Ltd
AU:MME
Australia AU$1.79 Billion
Do Day Dream Public Company Limited
BK:DDD
Thailand ฿309.00 Million
Analabs Resources Bhd
KLSE:7083
Malaysia RM305.62 Million
Shree Rama Newsprint Limited
NSE:RAMANEWS
India Rs5.47 Billion
Lay Hong Bhd
KLSE:9385
Malaysia RM449.20 Million
Penguen Gida Sanayi AS
IS:PENGD
Turkey TL2.54 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Intervacc AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Intervacc AB (IVACC) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 11.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.06 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Intervacc AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Intervacc AB (2013–2024)

The table below shows the annual total liabilities of Intervacc AB from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 Skr24.99 Million
≈ $2.69 Million
+15.26%
2023-12-31 Skr21.68 Million
≈ $2.33 Million
+45.74%
2022-12-31 Skr14.88 Million
≈ $1.60 Million
-29.63%
2021-12-31 Skr21.14 Million
≈ $2.28 Million
+19.63%
2020-12-31 Skr17.67 Million
≈ $1.90 Million
+2.48%
2019-12-31 Skr17.25 Million
≈ $1.86 Million
+40.97%
2018-12-31 Skr12.23 Million
≈ $1.32 Million
-17.03%
2017-12-31 Skr14.74 Million
≈ $1.59 Million
-55.95%
2016-12-31 Skr33.47 Million
≈ $3.60 Million
+17.72%
2015-12-31 Skr28.44 Million
≈ $3.06 Million
-46.08%
2014-12-31 Skr52.74 Million
≈ $5.68 Million
+4143.19%
2013-12-31 Skr1.24 Million
≈ $133.76K
--

About Intervacc AB

ST:IVACC Sweden Biotechnology
Market Cap
$47.68 Million
Skr443.06 Million SEK
Market Cap Rank
#22148 Global
#417 in Sweden
Share Price
Skr1.30
Change (1 day)
-0.76%
52-Week Range
Skr0.61 - Skr1.39
All Time High
Skr89.40
About

Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Stangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against streptococcus suis for the treatment of weaned piglets; and INV412, a multi-component vaccine to protect against several bacteria which cause mastitis for treating cows. It also engages… Read more